Serene COO Nigel Stevenson is President-Elect of WCI
Serene Chief Operating Officer, Nigel Stevenson, has been elected as President-elect of the World Council on Isotopes beginning November 2016.
Serene Chief Operating Officer, Nigel Stevenson, has been elected as President-elect of the World Council on Isotopes beginning November 2016.
Serene Chief Operating Officer, Nigel Stevenson, has been elected as 4th President of the World Council on Isotopes from November 2017 to November of 2020.
Serene, LLC, is pleased to announce the addition of Martin Manco, JD, MBA, who is responsible for finance, legal, and IP matters. As an attorney in private practice, Marty assisted in the founding of Serene and has represented the Company…
We are pleased to announce that we have changed our company name from R-NAV, LLC, to Serene, LLC.
Serene Chief Operating Officer, Nigel Stevenson, served as Member and Session Chairperson on the Technical Organization Committee of the 8th International Conference on Isotopes & Expo in Chicago Illinois, August 24-28, 2016.
Four abstracts have been accepted for presentation, three as posters and one as an oral presentation, at the 11th Annual International Conference on Radiopharmaceutical Therapy, November 13-16 in Cochin, India. The oral presentation is entitled, “Production and Characteristics of a Novel…
The abstract "Preclinical evaluation of Sn-117m colloid as a radiosynoviorthesis agent for treatment of canine elbow joint osteoarthrosis", has been accepted for oral presentation by clinical trial primary investigator Jimmy Lattimer DVM at the American College of Veterinary Radiology, October…
The pivotal trial of Synovetin OA used to treat elbow osteoarthritis in dogs has now completed the midway point. Gulf Coast Veterinary Specialists in Houston Texas, has enrolled dog #24, and continues to recruit subjects along with Missouri University College…
Two tin-117m-related abstracts have been accepted for presentation at the European Association of Nuclear Medicine 2016 Conference in Barcelona, Spain, October 2016, "117mSn colloid as a potential candidate to replace 169Er colloids in radiosynovectomy of small joints," and "Sn-117m colloid…
Three presentations were given regarding tin-117m at SNMMI in San Diego today. The presentations are "A Comparison of Er-169 and Sn-117m Radiation Synoviorthesis Using Monte Carlo Simulation," presented by Richard Wendt, PhD, "Retention and Biodistribution of Sn-117m Colloid in Intra-Articular Injections,"…